Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Western Uranium & Vanadium (WSTRF) EBT (2016 - 2025)

Western Uranium & Vanadium (WSTRF) has disclosed EBT for 8 consecutive years, with -$1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, EBT rose 49.64% to -$1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$8.5 million, a 5.94% increase, with the full-year FY2024 number at -$10.3 million, down 102.81% from a year prior.
  • EBT was -$1.1 million for Q3 2025 at Western Uranium & Vanadium, up from -$2.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $2.3 million in Q2 2022 to a low of -$2.8 million in Q4 2024.
  • A 5-year average of -$1.3 million and a median of -$1.1 million in 2023 define the central range for EBT.
  • Biggest YoY gain for EBT was 583.83% in 2022; the steepest drop was 301.71% in 2022.
  • Western Uranium & Vanadium's EBT stood at -$786885.0 in 2021, then tumbled by 69.77% to -$1.3 million in 2022, then fell by 29.11% to -$1.7 million in 2023, then plummeted by 62.0% to -$2.8 million in 2024, then surged by 59.64% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for WSTRF's EBT are -$1.1 million (Q3 2025), -$2.0 million (Q2 2025), and -$2.6 million (Q1 2025).